Your browser doesn't support javascript.
loading
Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial.
Bonnefoi, H; Litière, S; Piccart, M; MacGrogan, G; Fumoleau, P; Brain, E; Petit, T; Rouanet, P; Jassem, J; Moldovan, C; Bodmer, A; Zaman, K; Cufer, T; Campone, M; Luporsi, E; Malmström, P; Werutsky, G; Bogaerts, J; Bergh, J; Cameron, D A.
Afiliação
  • Bonnefoi H; Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, INSERM U916, Bordeaux, France h.bonnefoi@bordeaux.unicancer.fr.
  • Litière S; European Organisation for Research and Treatment of Cancer (EORTC), Brussels.
  • Piccart M; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • MacGrogan G; Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, INSERM U916, Bordeaux, France.
  • Fumoleau P; Centre George-François Leclerc, Dijon.
  • Brain E; Ensemble Hospitalier de L'Institut Curie, Hopital René Huguenin, St-Cloud.
  • Petit T; Centre Paul Strauss, Strasbourg.
  • Rouanet P; Centre Val D'Aurelle-Paul Lamarque, Montpellier, France.
  • Jassem J; Medical University, Gdansk, Poland.
  • Moldovan C; Centre Henri Becquerel, Rouen, France.
  • Bodmer A; Geneva University Hospital, Geneva Swiss Group for Clinical Cancer Research (SAKK), Bern.
  • Zaman K; Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
  • Cufer T; Institute of Oncology, Ljubljana University Clinic Golnik, Golnik, Slovenia.
  • Campone M; Institut de Cancérologie de L'Ouest (ICO), Centre René Gauducheau, Nantes Centre Paul Papin, Angers.
  • Luporsi E; Centre Alexis Vautrin, Nancy, France.
  • Malmström P; Department of Clinical Sciences, Lund University, Lund Skåne Department of Oncology, Skåne University Hospital, Lund.
  • Werutsky G; European Organisation for Research and Treatment of Cancer (EORTC), Brussels.
  • Bogaerts J; European Organisation for Research and Treatment of Cancer (EORTC), Brussels.
  • Bergh J; Swedish Breast Cancer Group (SweBCG), Stockholm Department of Oncology, Karolinska Institutet, Radiumhemmet and Karolinska University Hospital, Stockholm, Sweden.
  • Cameron DA; Cancer Services, Edinburgh University Anglo-Celtic Cooperative Oncology Group (ACCOG), Edinburgh, UK.
Ann Oncol ; 25(6): 1128-36, 2014 Jun.
Article em En | MEDLINE | ID: mdl-24618153
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Ductal de Mama / Terapia Neoadjuvante Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2014 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Ductal de Mama / Terapia Neoadjuvante Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2014 Tipo de documento: Article País de afiliação: França